Modernizing drug development and ensuring global equity in the organoid revolution
Global regulatory shifts are accelerating the move from animal models to human-relevant systems like organoids and MPS. Without deliberate inclusion, Africa risks exclusion despite its high disease burden, limiting global health equity and full scientific potential.
Authors
- Emmanuel Enoch Dzakah (ORCID: https://orcid.org/0000-0002-7475-6420)
- Shixing Tang
- Clifford Pang (ORCID: https://orcid.org/0009-0005-6242-3564)
- Xiaomin Feng
- Wei Hu
- Chao Ni
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Cell Technology (China) (HK)
- Viva Biotech (China) (CN)
- Southern Medical University (CN)
- Clifford Chance (GB)
Publication Details
- Journal
- Communications Biology
- Published
- 2026-04-17
- DOI
- https://doi.org/10.1038/s42003-026-10076-4
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00